OSRH

OSR Health, Inc.
CAPPED RATING

OSR Health, Inc. (OSRH) is rated C- (1.9/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B-); its weakest is Growth (F). The rating has held at C- for 9 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
1.9 / 5.0
C-
Value
B-
Factor Score 3.0 / 5.0
Growth
F
Factor Score 0.4 / 5.0
Profitability
B-
Factor Score 3.1 / 5.0
Momentum
F
Factor Score 0.6 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA -3.9
Rev Growth YoY -72.2%
Gross Margin 33.4%
Price Return 3M -80.8%
Price Return 12M -80.8%
Catalyst Signal 0.00
Market Cap $4.0M
TTM Revenue $1.8M
Price / Sales 2.2
ROE -11.3%

Historical Factor Score Progression

Held C- for 9 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (3.0) F (0.4) B- (3.1) F (0.6) C+ (2.6) C- (1.9)
2026-11-07 B- (3.0) F (0.3) B- (3.1) D- (0.7) C+ (2.7) C- (2.0)
2026-10-31 B- (3.0) F (0.3) B (3.2) F (0.7) C+ (2.7) C- (2.0)
2026-10-24 B- (3.0) F (0.3) B (3.2) D- (0.8) C+ (2.6) C- (2.0)
2026-10-17 B- (3.0) F (0.3) B (3.2) D- (0.8) C+ (2.6) C- (2.0)
Page 1 of 4